| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |